Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
2019 ◽
Vol 7
(7)
◽
pp. 515-527
◽
Ofri Mosenzon
◽
Thalia Marie Blicher
◽
Signe Rosenlund
◽
Jan W Eriksson
◽
Simon Heller
◽
...
2014 ◽
Vol 106
◽
pp. S31
◽
C. Mathieu
◽
G. Umpierrez
◽
S. Atkin
◽
S. Bain
◽
P. Rossing
◽
...
2016 ◽
Vol 7
(3)
◽
pp. 527-535
◽
Shira Perl
◽
William Cook
◽
Cheryl Wei
◽
Nayyar Iqbal
◽
Boaz Hirshberg
2020 ◽
Vol 69
(Supplement 1)
◽
pp. 136-LB
DAVID CHERNEY
◽
ELE FERRANNINI
◽
GUILLERMO E. UMPIERREZ
◽
ANNE L. PETERS
◽
JULIO ROSENSTOCK
◽
...
Melanie J. Davies
◽
Stephen C. Bain
◽
Stephen L. Atkin
◽
Peter Rossing
◽
David Scott
◽
...
2014 ◽
Vol 38
(5)
◽
pp. S9-S10
◽
Phuong Ngo
◽
Melanie Davies
◽
Stephen Atkin
◽
Stephen Bain
◽
Peter Rossing
◽
...
2018 ◽
Vol 20
(11)
◽
pp. 2532-2540
◽
Paola Fioretto
◽
Stefano Del Prato
◽
John B. Buse
◽
Ronald Goldenberg
◽
Francesco Giorgino
◽
...
2019 ◽
Vol 68
(Supplement 1)
◽
pp. 1004-P
◽
OFRI MOSENZON
◽
SIGNE ROSENLUND
◽
JAN W. ERIKSSON
◽
SIMON R. HELLER
◽
RICHARD E. PRATLEY
◽
...
2012 ◽
Vol 36
(2)
◽
pp. 237-244
◽
J. B. McGill
◽
L. Sloan
◽
J. Newman
◽
S. Patel
◽
C. Sauce
◽
...
2016 ◽
Vol 40
(5)
◽
pp. S47
Peter A. Senior
◽
Javier Escalada
◽
Serge Halimi
◽
Mireille Bonnemaire
◽
Anna M.G. Cali
◽
...
Close
Export Citation Format
Close
Share Document
Close